Athelas vs GE HealthCare
Side-by-side comparison of AI visibility scores, market position, and capabilities
SF healthcare tech with remote patient monitoring devices and AI medical billing for CCM/RPM programs; $132M General Catalyst and Sequoia backed generating $200-300/month per patient in additional practice revenue.
About
Athelas is a San Francisco-based healthcare technology company providing remote patient monitoring (RPM) devices and AI-powered medical billing automation for physicians managing patients with chronic conditions — enabling clinics to capture recurring CMS (Centers for Medicare & Medicaid Services) reimbursement for Chronic Care Management (CCM) and Remote Patient Monitoring programs that most practices fail to bill correctly or at all. Founded in 2016 by Tanay Tandon and Deepika Bodapati and backed with $132 million raised from General Catalyst, Sequoia Capital, and others, Athelas serves 1,000+ healthcare provider organizations with cellular-connected monitoring devices and automated billing workflow.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.
About
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.